Table 1

Effect of oats in the diet of adult patients with coeliac disease and gliadin and reticulin antibodies

VariableCoeliac disease in remissionNewly diagnosed coeliac disease
Oat group (n=26)Control group (n=26)p ValueOat group (n=19)Control group (n=21)p Value
Anti-gliadin IgA (EU/ml)
 Baseline0.0 (0–0.63)0.0 (0–0.68)0.55 (0–10.0)0.62 (0–10.0)
 1 month0.0 (0–0.64)0.0 (0–0.16)0.27 (0–10.0)0.29 (0–4.31)
 3 months0.0 (0–0.59)0.0 (0–0.96)0.14 (0–1.8)0.0 (0–7.46)
 6 months0.0 (0–0.85)0.0 (0–0.39)0.0 (0–1.9)0.0 (0–1.13)
 12 months0.0 (0–1.8)0.0 (0–1.45)
 Change0.0 (−0.47 to 0.41)0.0 (−0.31 to 0.03)0.33−0.73 (−9.9 to 0)−0.57 (−9.38 to 0)0.69
 Group difference (95% CI)0 (0 to 0.01)0 (−0.45 to 0.53)
Anti-gliadin IgG (EU/ml)
 Baseline0.86 (0–5.71)0.0 (0–5.17)7.82 (0–30.8)3.49 (0.65–61.2)
 1 month0.76 (0–6.72)0.56 (0–4.08)6.13 (0–26.5)5.41 (0.58–69.8)
 3 months0.72 (0–8.07)0.0 (0–3.86)3.95 (0–11.3)2.76 (0–22.1)
 6 months0.97 (0–7.4)0.0 (0–2.54)2.03 (0–6.23)1.97 (0–9.28)
 12 months1.15 (0–6.97)1.04 (0–9.2)
 Change0.0 (−1.21 to 2.02)0.0 (−2.63 to 0.86)0.12−7.09 (−29.85 to 0)−2.99 (−55.2 to 0.53)0.99
 Group difference (95% CI)0.18 (0 to 0.66)1.28 (−2.14 to 4.04)
Anti-reticulin IgA (EU/ml)
 Baseline0 (0–50)0 (0–50)200 (0–2000)200 (0–4000)
 1 month0 (0–5)0 (0–50)50 (0–200)0 (0–1000)
 3 months0 (0–5)0 (0–0)0 (0–200)0 (0–200)
 6 months0 (0–5)0 (0–0)0 (0–0)0 (0–8000)
 12 months0 (0–5)0 (0–50)
 Change0 (−50 to 0)0 (−50 to 0)1.0−200 (−2000 to 0)−175 (−4000 to 5)0.79
 Group difference (95% CI)0 (0 to 0)0 (−50 to 200)
  • Values are median (range), except for differences in changes (as medians) between the groups; 95% confidence intervals (CI) are shown in parentheses; p values were calculated using the Mann-Whitney U test.